DocuSign (DOCU) Projected to Post Quarterly Earnings on Thursday

DocuSign (NASDAQ:DOCU - Get Free Report) is expected to be releasing its Q1 2026 earnings data after the market closes on Thursday, June 5th. Analysts expect DocuSign to post earnings of $0.81 per share and revenue of $748.79 million for the quarter. DocuSign has set its FY 2026 guidance at EPS and its Q1 2026 guidance at EPS.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.02. The business had revenue of $776.25 million during the quarter, compared to analysts' expectations of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm's revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.76 earnings per share. On average, analysts expect DocuSign to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

DocuSign Stock Performance

Shares of DocuSign stock traded up $2.04 on Friday, hitting $87.75. 5,726,500 shares of the company's stock were exchanged, compared to its average volume of 2,783,615. DocuSign has a 1 year low of $48.70 and a 1 year high of $107.86. The company has a 50-day simple moving average of $81.65 and a 200-day simple moving average of $85.88. The stock has a market capitalization of $17.77 billion, a PE ratio of 18.09, a PEG ratio of 6.94 and a beta of 1.21.

Wall Street Analysts Forecast Growth

DOCU has been the topic of several analyst reports. JPMorgan Chase & Co. upgraded DocuSign from an "underweight" rating to a "neutral" rating and lifted their target price for the company from $70.00 to $75.00 in a research report on Monday, March 10th. Citigroup lifted their price objective on DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research report on Friday, March 14th. HSBC raised shares of DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 target price for the company in a report on Friday, April 11th. Jefferies Financial Group reduced their price objective on shares of DocuSign from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Monday, March 31st. Finally, Bank of America cut their price target on DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a research note on Friday, March 14th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $92.46.

Insider Activity

In related news, Director Teresa Briggs sold 534 shares of the company's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now owns 8,270 shares of the company's stock, valued at $722,880.70. This represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction on Tuesday, April 15th. The stock was sold at an average price of $76.09, for a total transaction of $608,720.00. Following the completion of the transaction, the chief financial officer now directly owns 86,156 shares of the company's stock, valued at $6,555,610.04. The trade was a 8.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 47,851 shares of company stock worth $3,912,239. 1.01% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in DocuSign stock. NewEdge Advisors LLC raised its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 36.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,202 shares of the company's stock after purchasing an additional 2,457 shares during the period. NewEdge Advisors LLC's holdings in DocuSign were worth $749,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 77.64% of the company's stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.